Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Dysregulated lipid metabolism is a key driver of follicular lymphoma (FL). This study aimed to explo...
Intensity-modulated proton therapy (IMPT) provides steep dose gradients but is vulnerable to range u...
Radiation skin injury (RSI) is an unavoidable side effect of radiotherapy that delays the treatment ...
This article examines global thyroid cancer(TC) incidence trends, with emphasis on epidemiological p...
Breast cancer heterogeneity limits the precision of current prognostic and therapeutic strategies, u...
Selective inhibition of hexokinase 2 (HK2) represents a promising therapeutic strategy due to the pi...
Clear cell renal cell carcinoma (ccRCC) is characterized by high metastatic potential and frequent r...
Machine learning and deep learning tools have been proposed to improve survival prediction in acute ...
Isocitrate dehydrogenase (IDH) enzymes have recently emerged as a highly promising target for therap...
Multiple myeloma (MM), long viewed as incurable, is entering a transformative era marked by deeper r...
NK and NKT cells act as major effector subsets across multiple immune heterogeneous cell populations...
The tumor microenvironment (TME) comprises diverse cellular components that spatially interact to fo...
Accurate and robust prediction of drug-target affinity (DTA) plays a critical role in drug discovery...
Lung cancer is a leading cause of cancer-related mortality worldwide, and its early and accurate det...
OBJECTIVE: Maxillary canine impaction affects approximately 1-3% of the population and presents diag...
BACKGROUND: Glioma was the most common malignant tumor of the central nervous system in adults. Low-...
OBJECTIVES: To develop and validate a deep learning model for whole breast clinical target volume (C...
OBJECTIVES: This study aimed to develop and validate machine learning (ML) models to predict surviva...
BACKGROUND: Deep neural networks (DNNs) are promising for analyzing high-dimensional transcriptomic ...
BACKGROUND: Cutaneous malignant melanoma (CMM) is a highly malignant tumor that necessitates early d...